Titan Biotech Board Meeting on Nov 5 for Q2 FY27 Results

Titan Biotech Ltd has announced that its Board of Directors will convene on November 5, 2026, to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2026. The meeting will also address any other business as permitted by the Chairman. Concurrently, the company has closed its trading window for designated persons from October 1, 2026, until 48 hours after the board meeting's outcome is declared, in compliance with SEBI's Insider Trading Regulations.